Bioavailability of Tiotropium + Olodaterol Fixed-dose Combination (5 μg/ 5 μg) in Chinese COPD Patients
Clinical trial NCT02969317 · COMPLETED
Trial details
- NCT number
- NCT02969317
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-24
- Primary completion
- 2017-06-15
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.